Post-Mortem Community Surveillance of COVID-19: Implementation and Evaluation of a Pilot System in the Funeral Sector in England, UK, January 2021 to February 2022

IF 4.3 4区 医学 Q1 INFECTIOUS DISEASES
Hannah E. Emmett, Jennifer Hall, Harriet H. Webster, Abigail Izzard, Anika Singanayagam, Maria Zambon, Gavin Dabrera
{"title":"Post-Mortem Community Surveillance of COVID-19: Implementation and Evaluation of a Pilot System in the Funeral Sector in England, UK, January 2021 to February 2022","authors":"Hannah E. Emmett,&nbsp;Jennifer Hall,&nbsp;Harriet H. Webster,&nbsp;Abigail Izzard,&nbsp;Anika Singanayagam,&nbsp;Maria Zambon,&nbsp;Gavin Dabrera","doi":"10.1111/irv.70116","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Early in the COVID-19 pandemic, due to limited testing, a potential gap in capturing SARS-CoV-2-positive community deaths was identified. Post-mortem testing for respiratory viruses had never been implemented in the United Kingdom.</p>\n </section>\n \n <section>\n \n <h3> Aim</h3>\n \n <p>Through implementing and evaluating a pilot, we aimed to establish feasibility and acceptability of post-mortem SARS-CoV-2 surveillance using funeral directors (FDs) to capture ‘missed’ COVID-19 community deaths.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Between January 2021 and February 2022, four FDs took upper respiratory tract samples from eligible people who died outside hospital. We tested for SARS-CoV-2 and other respiratory viruses using reverse transcription-polymerase chain reaction and matched results to the national COVID-19 mortality dataset. We evaluated the pilot for acceptability, data completeness and timeliness, and simplicity, using semi-structured interviews, a questionnaire, and data audit.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Two thousand eight hundred sixty-five deaths were handled by FDs: 998 were assessed for eligibility, 342 were eligible 81 were tested. Eight were SARS-CoV-2-positive, of which three were not identified by ante-mortem clinical testing. The programme was acceptable in principle to FDs and families, but FDs' participation was limited by the burden of legal requirements and existing workloads. Families' willingness to consent fluctuated (monthly consent rate 4–83%, overall 30%); fewer consented when overall cases were low. Completeness and timeliness of data was good. FDs judged the programme simple.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The pilot established feasibility and demonstrated, even with small numbers, the ability to detect ‘missed’ deaths. There were significant obstacles to implementation. Alternative settings for taking specimens are being explored instead to address this gap in national surveillance.</p>\n </section>\n </div>","PeriodicalId":13544,"journal":{"name":"Influenza and Other Respiratory Viruses","volume":"19 6","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.70116","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Influenza and Other Respiratory Viruses","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/irv.70116","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Early in the COVID-19 pandemic, due to limited testing, a potential gap in capturing SARS-CoV-2-positive community deaths was identified. Post-mortem testing for respiratory viruses had never been implemented in the United Kingdom.

Aim

Through implementing and evaluating a pilot, we aimed to establish feasibility and acceptability of post-mortem SARS-CoV-2 surveillance using funeral directors (FDs) to capture ‘missed’ COVID-19 community deaths.

Methods

Between January 2021 and February 2022, four FDs took upper respiratory tract samples from eligible people who died outside hospital. We tested for SARS-CoV-2 and other respiratory viruses using reverse transcription-polymerase chain reaction and matched results to the national COVID-19 mortality dataset. We evaluated the pilot for acceptability, data completeness and timeliness, and simplicity, using semi-structured interviews, a questionnaire, and data audit.

Results

Two thousand eight hundred sixty-five deaths were handled by FDs: 998 were assessed for eligibility, 342 were eligible 81 were tested. Eight were SARS-CoV-2-positive, of which three were not identified by ante-mortem clinical testing. The programme was acceptable in principle to FDs and families, but FDs' participation was limited by the burden of legal requirements and existing workloads. Families' willingness to consent fluctuated (monthly consent rate 4–83%, overall 30%); fewer consented when overall cases were low. Completeness and timeliness of data was good. FDs judged the programme simple.

Conclusion

The pilot established feasibility and demonstrated, even with small numbers, the ability to detect ‘missed’ deaths. There were significant obstacles to implementation. Alternative settings for taking specimens are being explored instead to address this gap in national surveillance.

2019冠状病毒病死后社区监测:2021年1月至2022年2月英国英格兰殡葬业试点系统的实施和评估
在COVID-19大流行早期,由于检测有限,在捕获sars - cov -2阳性社区死亡人数方面发现了潜在的差距。英国从未实施过呼吸道病毒的死后检测。目的:通过实施和评估一项试点,我们旨在确定利用殡仪人员(FDs)进行死后SARS-CoV-2监测的可行性和可接受性,以捕获“遗漏”的COVID-19社区死亡病例。方法在2021年1月至2022年2月期间,4名FDs从符合条件的院外死亡患者中采集上呼吸道样本。我们使用逆转录聚合酶链反应检测了SARS-CoV-2和其他呼吸道病毒,并将结果与国家COVID-19死亡率数据集进行了匹配。我们使用半结构化访谈、问卷调查和数据审计来评估试点的可接受性、数据的完整性和及时性以及简单性。结果FDs共处理死亡病例2865例,合格评定998例,合格342例,检验81例。8人呈sars - cov -2阳性,其中3人未通过死前临床检测确定。该方案原则上可为家庭佣工和家庭所接受,但家庭佣工的参与受到法律规定的负担和现有工作量的限制。家庭同意意愿波动(月同意率4-83%,整体30%);当总体病例数较低时,同意的人数较少。数据的完整性和及时性较好。金融机构认为这个项目很简单。该试点建立了可行性,并证明了即使数量很少,也有能力发现“漏诊”死亡。在执行方面存在重大障碍。正在探索采集标本的其他环境,以解决国家监测中的这一差距。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.20
自引率
4.50%
发文量
120
审稿时长
6-12 weeks
期刊介绍: Influenza and Other Respiratory Viruses is the official journal of the International Society of Influenza and Other Respiratory Virus Diseases - an independent scientific professional society - dedicated to promoting the prevention, detection, treatment, and control of influenza and other respiratory virus diseases. Influenza and Other Respiratory Viruses is an Open Access journal. Copyright on any research article published by Influenza and Other Respiratory Viruses is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信